The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Krishana Phoschem Limited is an India-based company, which is primarily engaged in the business of fertilizer manufacturing and other products that are backward integration. The Company is also engaged in the manufacturing of Beneficiated Rock Phosphate (BRP), Single Super…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, fast-growing business, priced for perfection — but flagged on governance.
KRISHANA PHOSCHEM LIMITED is scored on the commodity / cyclical framework. It keeps a slim 7.4% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT -1.06×) — worth a closer look. Free cash flow is worth about -4.1% of its market value.
Over the last 3 years revenue compounded at 96%/yr and profit at 89%/yr. Book value itself has compounded 29%/yr — the hallmark of a genuine compounder. Return on equity is an elite 32.1%. In the latest quarter profit fell 43% versus the prior quarter.
At 2× earnings, the stock sits at the 96th percentile of its own 3.6-year range — the expensive end of where it has historically traded. Today's price implies ~18%/yr earnings growth for a decade. The forensic screen raises a red flag: Only ₹-0.46 of cash per ₹1 profit over 4 years — earnings not converting to cash.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 38.33 | 28.59 | worse |
| P/B | 13.44 | 8.11 | worse |
| EV/EBITDA | 24.29 | 18.35 | worse |
| ROE | 32.13 | 18.47 | better |
| ROCE | 21.14 | 10.44 | better |
| ROA | 11.99 | 5.88 | better |
| Quick Ratio | 0.99 | 4.44 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Coromandel Interntl | 30.3 | 4.3 | 15.6% |
| FACT | 1743.1 | 35.3 | 6.6% |
| Chambal Fertilizers | 8.1 | 1.4 | 16.8% |
Revenue has grown every year across all 4 financial years shown. 96% CAGR over 3 years — high-growth territory. Growth is accelerating — latest year outpaced the prior year's rate.
Net profit has risen every year — the hallmark of a compounder. Revenue is outpacing profit (96% vs 89%) — costs are rising faster than the top line. The latest year saw a +108% swing — check if it's a one-off or structural.
Operating margin has compressed from 12% to 10% — costs or competition are eating into profitability.
ROE at 32% — the business earns well above its cost of equity. High ROE despite single-digit margins — an asset-turn play with high capital velocity. Capital efficiency improving — ROE up 22pp across the window.
Profit grew faster than EPS (89% vs 49%) — share dilution is eroding per-share value. 49% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
3 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Investing outflows exceed operating cash — the company relies on external funding to finance expansion.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue fell 29% QoQ — could be seasonality or a genuine slowdown.
Profit fell 43% QoQ — one-quarter drops can be noise, but a pattern matters. Quarterly net margins are expanding (5% → 9%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters hold 72.9% — heavily owner-operated with strong skin in the game. FIIs have accumulated for 3 straight quarters — sustained foreign institutional conviction.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.